Eric Hoffman, PhD, writes a lot of grants, proposals and papers. A lot. As Professor and Associate Dean of Research at Binghamton University following stints at George Washington University, Harvard Medical School, and University of Pittsburgh, Dr Hoffman is used to writing a lot.
He also writes grants and proposals for his other job as CEO of Reveragen BioPharma – a small biotech company that has slowly developed a drug to treat boys with Duchenne muscular dystrophy.
{iframe}http://www.raredr.com/news/actelion-reveragen{/iframe}